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Joelle FS Wong* and Melissa CC TeoAbstract
This is a case of metastatic lung cancer of the lymphoepithelial-like carcinoma (LELC) variant who first presented
with symptomatic brain metastasis. The patient underwent local and systemic treatment for metastatic disease
with good clinical outcome. The patient was disease free for four years then she had primary lung recurrence
which was surgically resected. She underwent a second course of chemotherapy with saw her through another
two years of disease free period. A recurrence of the cancer was detected intra-abdominally on the seventh year of
diagnosis. This was treated again with surgical resection and another course of chemotherapy.
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We report a case of primary non-small cell lung cancer
of the lymphoepithelioma variant in a woman who pre-
sented with symptomatic brain metastasis. She under-
went initial treatment with chemo-radiation therapy to
her brain metastasis and primary lung tumor. Post treat-
ment, she enjoyed a significant disease free interval of 4
years but returned with local recurrence in the lungs
which was treated with local resection. She remained
disease-free on surveillance until 2 years later when a
new soft tissue mass was detected at the retroperitoneal/
posterior mediastinal region. The patient underwent a
second operation to resect the new lesion. Histology
again confirmed lymphoepithelioma-like carcinoma con-
sistent with metastatic disease. Currently she is disease-
free after two major surgeries, two sessions of radiother-
apy and 3 courses of chemotherapy, 8 years post initial
diagnosis of metastatic cancer.Case presentation
LGH, a 52 year old Chinese female, initially presentated
with generalized seizures with no other complaints or
symptoms in 2003. She had three separate episodes of
generalized seizures over the course of three months be-
fore presenting at the hospital. Her attacks were* Correspondence: joelle@asia.com
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reproduction in any medium, provided the orwitnessed by family and was described as a sudden loss
of consciousness lasting approximately 10 minutes and
associated with drooling and mild tonic phase with
spontaneous recovery.
Clinically, she had no focal neurological deficit, cogni-
tive dysfunction or visual disturbances. Her other sys-
tems review was also unremarkable. A magnetic
resonance imaging (MRI) scan of the brain showed a
mass in the left parieto-occipital lobe, in the parasagittal
location with mixed solid cystic component measuring
approximately 3.5x2.4x2.1 cm with surrounding vaso-
genic oedema. However there was no significant mass ef-
fect to cause ventricular deviation or cerebral herniation.
The impression was that of metastatic brain tumour.
Computer tomographic (CT) scans of the thorax, ab-
domen and pelvis was performed to investigate for a pri-
mary lesion. The scans showed a 2.3x 2.3 cm lesion
localized in the right lung as the only significant abnor-
mal lesion. (Figure 1).
A transthoracic needle aspiration of the lung lesion
confirmed the tumour to be an undifferentiated carcin-
oma of the lungs favouring a lymphoepithelial-like car-
cinoma. The tumour stained positively for Epstein-barr
virus (EBV) on in-situ hybridization (ISH) studies. A
computer tomographic (CT) scan of the postnasal space
done showed no abnormality or other evidence to sug-
gest a primary EBV-related nasopharyngeal or salivary
gland type carcinoma. Nasal endoscopy was also per-
formed by the otolaryngologist and was negative forral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Pulmonary LELC in right lung with brain metastasis
seen in left parieto-occipital lobe with localized mass effect
and surrounding vasogenic oedema.
Figure 2 Pulmonary LELC with brain metastasis after initial
radio and chemotherapy. Size of brain metastasis is smaller with
decrease in surrounding oedema and mass effect.
Figure 3 Pulmonary LELC with local recurrence in right lung
(pre-resection).
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Further review of the scans did not show significant
lymphadenopathy to implicate lymphoma (Burkitt,
Hodgkin’s and non-Hodgkin’s) as the pathogenesis of
malignancy.
Her case was discussed at a multidisciplinary tumour
board meeting. The treatment plan decided by the panel
was first to treat her symptoms of seizures with targeted
radiotherapy to her brain metastasis, followed by tar-
geted treatment for her primary lung carcinoma. Treat-
ment goals were to control disease related symptoms
and to prolong survival.
She underwent 13 days of whole brain radiotherapy
(WBRT) at 30 Gy as initial treatment with minimum
side effects. Her seizures were well controlled by oral
anti-epileptic drug (phenytoin) with no occurrence of
seizure during and after the course of radiotherapy.
Her post treatment scans showed minimal post radio-
therapy oedema that was managed well with corticoster-
oids. There was no evidence of widespread disease
within the brain post WBRT. Her bone scan showed no
evidence of metastatic bone disease at this stage. In view
of her response to the initial therapy and her good per-
formance status, a chemo-radio therapeutic regimen was
planned for treatment of the primary lung lesion.
A Platinum-based chemotherapy regimen (Paclitaxel/
Carboplatin) was given concurrently with a total dose of
60 Gy radiation therapy in 30 cycles divided into 2
phases, completed in 6 weeks. Using stereotatic radio-
therapy techniques, the external treatment radiation
beam was directed to conform to the shape of the lung
tumor, hence minimizing the toxicity of radiation to the
surounding tissue.
She remained well on follow-up with no evidence of
recurrence on surveillance scans (Figure 2). Post treat-
ment, she developed delayed drug hypersensitivity syn-
drome to phenytoin. This was managed with oral and
topical corticosteriods and her seizures remained well
controlled with the change of her anti-epileptic drug to
Levetiracitam.LGH continued with regular surveillance follow-up
with no evidence of recurrence on surveillance CT
brain, thorax, abdomen and pelvis for 4 years post treat-
ment. In the 5th year, her surveillance scans showed a
new local recurrence in the lung (Figure 3). The decision
was made for surgical resection of the local recurrence,
considering the resectability of the tumor and the fact
that she had already received full-dose chemoradiation
treatment to the same anatomical region.
The patient underwent a right middle lobectomy. The
resected tumor was well confined with a microscopic di-
mension of 3 cm. The pleura, bronchovascular and par-
enchymal margins were all free from tumor. A total of
17 benign lymph nodes were resected.
She recovered uneventfully from the thoracotomy. Post-
operatively, she underwent four cycles of Platinum-based
combination (Gemcitabine/ Carboplatin) chemotherapy.
She remained disease-free for another 2 years. In her
7th year post diagnosis, her surveillance scans revealed a
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posterior mediastinal region. (Figure 4)
In view of her long disease free interval and good re-
sponse to treatment, LGH was offered and proceeded to
a resection of the new retroperitoneal soft tissue mass.
During surgery, the mass was approached intraabdomin-
ally via an upper midline incision. Complete excision
was made possible by dividing the arcuate ligament and
widening the oesophageal hiatus, hence avoiding a med-
iastinotomy. The mass was found adjacent to foregut
derivatives like the oesophagus and stomach but with no
gross evidence of invasion. The diaphramatic defect was
repaired and a right chest tube was inserted post
operatively.
Her post operative recovery was unremarkable. The
histology confirmed the tumour to be a metastasis of the
primary lung lymphoepithelioma-like carcinoma. LGH
went on to receive her third course of Platinum-based
combination regimen (Docetaxel/ Carboplatin).
She remains well and disease-free six months after her
most recent surgery and eight years from her initial
presentation.Discussion
Lymphoepithelial-like carcinoma are uncommon can-
cers. They are usually found in pharyngeal and foregut
derivatives like salivary glands, thymus, stomach and
liver. However, recent cases of LELC detected in other
anatomical locations were also reported, such as bladder
[1], lacrimal glands [2], ovaries [3], cervix [4], skin [5]
etc. Since the first reported case of LELC in the lower
respiratory tract by Begin [6] et al, there has beenFIGure 4 Soft tissue mass discovered at the retoperitoneal/
mediastinal region (pre-resection).approximately 150 reported cases of lung LELC world-
wide in the literature.
Majority of the reported cases of LELC in current lit-
erature are stage III or lower. This is a case report of
stage IV metastatic lymphoepithelioma-like carcinoma
(LELC) of the lungs which presented with synchronous
brain metastasis. It is unique as it illustrates a case of
treated metastatic NSCLC that far exceeded her pre-
dicted life expectancy. With ongoing surveillance and
treatment, selected advanced cancers can be managed
like a chronic disease.
Histopathologically, LELC is similar to undifferentiated
nasopharyngeal carcinoma (NPC). It is characterized by a
diffused growth of epithelial cells on a background of in-
flammatory cells, predominantly lymphocytes. Lung
LELCs are less common, accounting for only 0.15 [7] to
3.6% [8] of all lung carcinoma with most of the literature
published on the Asian population. LELC of the lung has
been shown to have an association with EBV infection.
This is especially so in the Asian Chinese population but
not the Caucasian population. LELCs of the bladder, skin,
vagina, and cervix have no EBV association [9].
Case studies have shown association of silicosis with
LELC of the lungs where occupational exposure to silica
dust is implicated to result in carcinogenesis [10]. There
is also an excess of lung cancer cases in silicosis registry.
Although pathogenesis of carcinoma has been estab-
lished in animal studies but human meta-analyses of the
epidemiology studies have not been conclusive of this re-
lationship [11,12]. It was however reported that silica-
exposed workers have a relative risk of 1.3 and higher at
2.8 if workers are silicotic. Hence, it is recommended by
the National Institute for Occupational Safety and Health
(NIOSH) in the United States that crystalline silica be
considered a potential occupational carcinogen [13].
Patients wih lung LELC are often 10 years younger
than patients with other histological subtypes of NSLCs.
Our patient from this reported case is a 52 year old
Chinese female who fits the commonly reported LELC
profile of a non-smoker who is of Asian descent close to
the median age of 48 years old.
She first presented with symptoms suggestive of a
space occupying lesion in the cranium causing general-
ized seizures. Primary brain tumours were considered as
the initial diagnosis but metastatic brain tumors could
not be ruled out. The most common primary malignan-
cies linked to brain metastasis are lung, breast, skin and
colonic. After a proper oncological work up, a lung pri-
mary with metastasis to the brain is identified.
When lung biopsies turn up positive for carcinoma,
coupled with the identification of EBV infection, NPC pri-
mary with lung metastasis has to be excluded first. Differ-
entiation in the diagnosis of primary lymphoepithelioma
versus primary NPC with metastasis to lungs is necessary
Wong and Teo World Journal of Surgical Oncology 2012, 10:91 Page 4 of 6
http://www.wjso.com/content/10/1/91due to the different approach in management. Radiation
is the mainstay of treatment in NPC. On the contrary,
surgery is the major curative modality for NSCLC and in
higher stage carcinomas, radio-chemotherapy is often
planned post-operatively. Hence any mistaken histo-
pathological conclusions made would result in improper
cancer staging and patient management.
Radiologically on CT, both primary lung cancer lesions
and metastic NPC lung lesions are indistinguishable.
Pathologically, both are similarly associated to EBV in-
fection. Figure 5 This case highlights the importance of
avoiding the diagnostic pitfall of assuming that the lung
biopsy of a LELC points definitely to a primary carcin-
oma of the lung.
Early stage presentation of LELC can often be picked up
on CT as poorly circumscribed, peripherally placed
nodules <3.5 cm and not associated with lymphadenop-
athy [14,15]. The conclusion for advanced stage disease on
the other hand showed features of large, well circum-
scribed, centrally located lesions with evidence of vascular
encasement and peribronchovascular lymphadenopathy.
These features are also similarly seen in primary broncho-
genic carcinoma [16]. In our reported case of LELCFigure 5 Lung tissue from lobectomy showing malignant LELC
cells (H&E stain x10) and positive EBV insitu hybridization
(EBER – ISH x10) Stained brown. Magnification x10.presenting to us at stage IV disease with brain metastasis,
the primary lung carcinoma on CT imaging was well-
defined with lobulated margins and associated with ipsilat-
eral hilar lymphadenopathy.
The characteristics of LELC on MRI are non-specific
but are helpful in staging (eg. neural invasion) and pre-
operative planning.
Positron Emission Tomographic (PET) imaging pro-
vides an alternative non-invasive method of determining
the malignant potential of solitary pulmonary nodule.
PET/CT was significantly more sensitive (96% vs 81%;
p< 0.05) and accurate (93% vs 85% p= 0.011) than CT
alone in characterizing lung nodules [17]. However, fur-
ther characterization and identification of the nodule
still requires a multi-disciplinary approach with deter-
mination of histological sub-type, grading and TNM
staging for more precise diagnosis and prognosis [18].
PET imaging was not used in our reported case. How-
ever, in the case reported by cheng et al, the LELC of the
lung was picked up on CT but was not suspicious on
PET scan done approximately two years after initial pres-
entation, showing a standardized uptake value (SUV) of
<2.5 (considered malignant >3.5 SUV) [17,19]. Hence
PET imaging alone might be of limited benefit in the case
of LELC of the lung.
The patient in this case was diagnosed with stage IV
lung cancer and was treated aggressively with multimod-
ality treatment options of surgery, chemotherapy and
radiotherapy. First she underwent symptomatic radio-
therapy for her brain metastasis with good results, then
further courses of radiation and chemotherapy to the pri-
mary lung cancer site. Surgery was offered to her when
she returned after an interval of disease free period of
five years with local recurrence of her lung primary. She
recovered well from the thoracotomy. In view of patient’s
complete resection of the primary lung tumour with no
lymph node involvement, adjuvant chemotherapy was
again offered to her. According to the new WHO classifi-
cation of lung tumours [20], lymphoepithelioma-like car-
cinoma is recognised as a variant subtype of large cell
carcinoma of the lung. The guidelines [21] recommend
the use of adjuvant chemotherapy in patients with stages
IIA/B to IIIA NSCLC in which the tumours have been
completely resected for increase survival benefits. Hence
after a second course of platinum-based chemotherapy,
her survival was prolonged by another two years.
Prognosis studies and long term studies on effects of
various treatment modalities of primary lung LELC are
limited. It has been reported that lung LELC has a statis-
tically significant better prognosis than other NSCLCs
[22,23]. Han et al found significant difference in survival
rate of LELC compared with non-LELC in their retro-
spective cohort study. This is seen in the 2-year and
5-year survival rates of treated pulmonary LELC. The
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80.8% and 60.6% respectively (P< .05).
This case illustrates the primary treatment objective of
advance stage LELC disease can be more than just im-
proving quality of life and survival. With its better prog-
nosis and prolonged stable disease state as seen in this
case, selected patients with good functional status, if
detected at an early stage, can be managed with curative
intent.
Latent EBV infection of epithelial cells has been impli-
cated in the pathogenesis of NPC. However, the carcino-
genesis of LELC is still unclear and the association with
EBV induced tumourigenesis is uncertain with the ab-
sence of association with EBV genome in the Caucasian
LELC lung population and the low incidence of tobacco
smoking history in this population of lung cancer [24].
Future studies can be done to explore the natural history
of LELC, its metastatic behaviour and comparison be
made to define the clinicopathologic or molecular char-
acteristics of carcinoma from the various anatomical
sites. Current studies of the oncogenesis of EBV infec-
tion can also be further explored, comparing the post
treatment prognosis of EBV associated versus non-EBV
associated LELC.Conclusion
We report of a case of metastatic LELC of the lungs
which is a subtype of non small cell lung cancer. The as-
sociation of LELC with EBV infection is still uncertain
but the detection of viral DNA definitely facilitates diag-
nosis especially in the Asian population subgroup. It car-
ries a better prognosis than any other type of NSCLCs.
It is shown to be both radio and chemo sensitive. Good
survival outcome can be attained even with stage IV dis-
ease, if treated aggressively on diagnosis with chemora-
diation, supplemented with surgical resection. It is
important to establish cross disciplinary collaboration in
order to optimize the various treatment modalities of
surgery, chemotherapy and radiotherapy, all available to
treat LELC. This maximizes the patient’s lifespan bring-
ing him/her to the next juncture where targeted cancer
therapies become available and can be selectively
adopted for further treatment of the primary cancer.Consent
Written informed consent was obtained from the patient
for publication of this report and accompanying images.
A copy of written consent is available for review if
requested.
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